210 related articles for article (PubMed ID: 33481180)
1. Exploration for the real causative agents of licorice-induced pseudoaldosteronism.
Makino T
J Nat Med; 2021 Mar; 75(2):275-283. PubMed ID: 33481180
[TBL] [Abstract][Full Text] [Related]
2. 18β-glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism.
Ishiuchi K; Morinaga O; Ohkita T; Tian C; Hirasawa A; Mitamura M; Maki Y; Kondo T; Yasujima T; Yuasa H; Minamizawa K; Namiki T; Makino T
Sci Rep; 2019 Feb; 9(1):1587. PubMed ID: 30733510
[TBL] [Abstract][Full Text] [Related]
3. 3-Monoglucuronyl glycyrrhretinic acid is a possible marker compound related to licorice-induced pseudoaldosteronism.
Makino T
Biol Pharm Bull; 2014; 37(6):898-902. PubMed ID: 24882402
[TBL] [Abstract][Full Text] [Related]
4. Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study.
Takahashi K; Yoshino T; Maki Y; Ishiuchi K; Namiki T; Ogawa-Ochiai K; Minamizawa K; Makino T; Nakamura T; Mimura M; Watanabe K
Arch Toxicol; 2019 Nov; 93(11):3111-3119. PubMed ID: 31605160
[TBL] [Abstract][Full Text] [Related]
5. 3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11β-hydroxysteroid dehydrogenase 2.
Makino T; Okajima K; Uebayashi R; Ohtake N; Inoue K; Mizukami H
J Pharmacol Exp Ther; 2012 Aug; 342(2):297-304. PubMed ID: 22543032
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism.
Morinaga O; Ishiuchi K; Ohkita T; Tian C; Hirasawa A; Mitamura M; Maki Y; Yasujima T; Yuasa H; Makino T
Sci Rep; 2018 Oct; 8(1):15568. PubMed ID: 30348944
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.
Makino T; Ohtake N; Watanabe A; Tsuchiya N; Imamura S; Iizuka S; Inoue M; Mizukami H
Drug Metab Dispos; 2008 Jul; 36(7):1438-43. PubMed ID: 18362159
[TBL] [Abstract][Full Text] [Related]
8. Identification of an Alternative Glycyrrhizin Metabolite Causing Liquorice-Induced Pseudohyperaldosteronism and the Development of ELISA System to Detect the Predictive Biomarker.
Ishiuchi K; Morinaga O; Yoshino T; Mitamura M; Hirasawa A; Maki Y; Tashita Y; Kondo T; Ogawa K; Lian F; Ogawa-Ochiai K; Minamizawa K; Namiki T; Mimura M; Watanabe K; Makino T
Front Pharmacol; 2021; 12():688508. PubMed ID: 34079468
[TBL] [Abstract][Full Text] [Related]
9. Clinical Risk Factors of Licorice-Induced Pseudoaldosteronism Based on Glycyrrhizin-Metabolite Concentrations: A Narrative Review.
Yoshino T; Shimada S; Homma M; Makino T; Mimura M; Watanabe K
Front Nutr; 2021; 8():719197. PubMed ID: 34604277
[TBL] [Abstract][Full Text] [Related]
10. 3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism.
Kato H; Kanaoka M; Yano S; Kobayashi M
J Clin Endocrinol Metab; 1995 Jun; 80(6):1929-33. PubMed ID: 7775643
[TBL] [Abstract][Full Text] [Related]
11. A possible involvement of 3-monoglucuronyl-glycyrrhetinic acid, a metabolite of glycyrrhizin (GL), in GL-induced pseudoaldosteronism.
Ohtake N; Kido A; Kubota K; Tsuchiya N; Morita T; Kase Y; Takeda S
Life Sci; 2007 Apr; 80(17):1545-52. PubMed ID: 17331546
[TBL] [Abstract][Full Text] [Related]
12. A Study of Factors Associated with the Development of Pseudoaldosteronism in Outpatients.
Mantani N; Oka H; Watanabe T
J Altern Complement Med; 2020 Apr; 26(4):329-334. PubMed ID: 31977240
[No Abstract] [Full Text] [Related]
13. Risk factors for pseudoaldosteronism with rhabdomyolysis caused by consumption of drugs containing licorice and differences between incidence of these conditions in Japan and other countries: case report and literature review.
Yoshino T; Yanagawa T; Watanabe K
J Altern Complement Med; 2014 Jun; 20(6):516-20. PubMed ID: 24620820
[TBL] [Abstract][Full Text] [Related]
14. [Scientific Evaluation of Crude Drugs and Kampo Medicines Using the Eastern Blotting Method and Its Application to Biological Metabolic Studies].
Morinaga O
Yakugaku Zasshi; 2018; 138(6):743-750. PubMed ID: 29863039
[TBL] [Abstract][Full Text] [Related]
15. [Adverse effects of licorice consumed as food: An update].
Caré W; Grenet G; Schmitt C; Michel S; Langrand J; Le Roux G; Vodovar D
Rev Med Interne; 2023 Sep; 44(9):487-494. PubMed ID: 37005098
[TBL] [Abstract][Full Text] [Related]
16. A semi-physiologically based pharmacokinetic pharmacodynamic model for glycyrrhizin-induced pseudoaldosteronism and prediction of the dose limit causing hypokalemia in a virtual elderly population.
Xu R; Liu X; Yang J
PLoS One; 2014; 9(12):e114049. PubMed ID: 25463381
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis: A retrospective cohort study.
Komatsu A; Yoshino T; Suzuki T; Nakamura T; Kanai T; Watanabe K
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):607-614. PubMed ID: 30471199
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule.
Lan XF; Olaleye OE; Lu JL; Yang W; Du FF; Yang JL; Cheng C; Shi YH; Wang FQ; Zeng XS; Tian NN; Liao PW; Yu X; Xu F; Li YF; Wang HT; Zhang NX; Jia WW; Li C
Acta Pharmacol Sin; 2021 Dec; 42(12):2155-2172. PubMed ID: 33931765
[TBL] [Abstract][Full Text] [Related]
19. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice.
Shibata S
Yakugaku Zasshi; 2000 Oct; 120(10):849-62. PubMed ID: 11082698
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinical factors associated with Kampo formula-induced pseudoaldosteronism based on self-reported information from the Japanese Adverse Drug Event Report database.
Uneda K; Kawai Y; Kaneko A; Kayo T; Akiba S; Ishigami T; Yoshida-Komiya H; Suzuki M; Mitsuma T
PLoS One; 2024; 19(1):e0296450. PubMed ID: 38165850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
